Overview

Effect of Heat on Rivastigmine TDS Products

Status:
Completed

Trial end date:
2021-05-04

Target enrollment:

Participant gender:

Summary

This research study is designed to measure the amount of medicine in blood over time after the patch is placed on the skin with and without external heat application.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Maryland
University of Maryland, Baltimore

Collaborator:

Food and Drug Administration (FDA)

Treatments:

Rivastigmine